title: Ibuprofen rescues abnormalities in periodontal tissues in conditional presenilin 1 and presenilin 2 double knockout mice.
abstract: We used forebrain-specific conditional presenilin 1 (PS1) and presenilin 2 (PS2) double knockout mice (dKO mice) that exhibit symptoms of neurodegenerative diseases, especially Alzheimer's disease, to investigate whether ibuprofen can rescue brain and periodontal tissue abnormalities by attenuating the inflammatory response. Mandibles were dissected for alveolar bone-height analysis. Maxillae were fixed and decalcified for histological observation and osteoclast detection. ELISA measurements from the hippocampus, cortex, and gingiva of the mandibular incisor teeth were used to assay inflammatory mediators. We confirmed periodontal tissue abnormalities and inflammatory responses in brain and periodontal tissues in naive nine- and 12-month-old dKO mice. The other two groups of age-matched dKO mice that received 375-ppm ibuprofen treatment for six consecutive months exhibited significantly attenuated damage in periodontal tissues and reduction in several inflammation-related factors in brain and periodontal tissues. Our findings showed that the anti-inflammatory drug ibuprofen significantly decreased inflammation through the cyclooxygenase (COX) pathway in brain and periodontal tissues in dKO mice, and then attenuated abnormalities in periodontal tissues. This suggests that ibuprofen could be an ideal drug for preventing both nervous system and periodontal tissue damage caused by inflammatory responses.
authors.affiliation: Laboratory of Oral Biomedical Science and Translational Medicine, School of Stomatology, Tongji University, Middle Yanchang Road 399, Shanghai 200072, China. sjs@tongji.edu.cn.
authors.forename: Jiansheng
authors.initials: J
authors.lastname: Su
authors.forename: Jiamei
authors.initials: J
authors.lastname: Gu
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Dong
authors.forename: Bing
authors.initials: B
authors.lastname: Mei
mesh_terms: D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D007052:Ibuprofen / Q000627:therapeutic use*; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D010510:Periodontal Diseases / Q000188:drug therapy* / Q000378:metabolism*; D010519:Periodontium / Q000378:metabolism*; D053764:Presenilin-1 / Q000172:deficiency* / Q000235:genetics; D053766:Presenilin-2 / Q000172:deficiency* / Q000235:genetics
chemical_list: D053764:Presenilin-1; D053766:Presenilin-2; D007052:Ibuprofen
references.citation: Neurobiol Aging. 2001 Nov-Dec;22(6):983-91
references.pmid: 11755007
references.citation: Proc Natl Acad Sci U S A. 2004 May 25;101(21):8162-7
references.pmid: 15148382
references.citation: J Alzheimers Dis. 2012;28(3):613-24
references.pmid: 22045483
references.citation: J Periodontol. 2008 Aug;79(8 Suppl):1569-76
references.pmid: 18673012
references.citation: J Neurosci. 2000 Aug 1;20(15):5709-14
references.pmid: 10908610
references.citation: Hum Mol Genet. 1997;6(10):1639-46
references.pmid: 9300655
references.citation: Ann Anat. 1998 Dec;180(6):519-22
references.pmid: 9862031
references.citation: Periodontol 2000. 2004;34:9-21
references.pmid: 14717852
references.citation: Mol Cell Biochem. 2011 Jan;347(1-2):13-20
references.pmid: 20953898
references.citation: Neurobiol Aging. 2000 May-Jun;21(3):383-421
references.pmid: 10858586
references.citation: Neurology. 2008 May 6;70(19):1672-7
references.pmid: 18458226
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):403-9
references.pmid: 17197420
references.citation: J Clin Periodontol. 2009 Jul;36(7):550-7
references.pmid: 19538327
references.citation: Neuron. 2004 Apr 8;42(1):23-36
references.pmid: 15066262
references.citation: Neurology. 1997 Mar;48(3):626-32
references.pmid: 9065537
references.citation: Drugs Aging. 2000 Jul;17(1):1-11
references.pmid: 10933512
references.citation: J Neurosci. 2003 Mar 1;23(5):1605-11
references.pmid: 12629164
references.citation: J Am Dent Assoc. 2009 Nov;140(11):1392-400
references.pmid: 19884398
references.citation: Genes Dev. 1999 Nov 1;13(21):2801-10
references.pmid: 10557208
references.citation: Brain. 2005 Jun;128(Pt 6):1442-53
references.pmid: 15817521
references.citation: N Engl J Med. 2001 Nov 22;345(21):1515-21
references.pmid: 11794217
references.citation: Brain Res Mol Brain Res. 1998 Sep 18;60(1):40-9
references.pmid: 9748493
references.citation: J Am Geriatr Soc. 2008 Jan;56(1):59-67
references.pmid: 18028345
references.citation: Pharmacol Rev. 2004 Sep;56(3):387-437
references.pmid: 15317910
references.citation: Neurology. 1996 Aug;47(2):425-32
references.pmid: 8757015
references.citation: Eur J Neurosci. 2007 Jul;26(1):101-12
references.pmid: 17614943
references.citation: Biochem Biophys Res Commun. 2011 Jul 1;410(2):229-34
references.pmid: 21651893
references.citation: Gerodontology. 2004 Mar;21(1):17-26
references.pmid: 15074536
references.citation: J Alzheimers Dis. 2009;18(3):515-23
references.pmid: 19584449
references.citation: Am J Pathol. 1998 Sep;153(3):767-83
references.pmid: 9736027
references.citation: J Am Geriatr Soc. 2010 Apr;58(4):713-8
references.pmid: 20398152
references.citation: Psychosom Med. 2008 Oct;70(8):936-41
references.pmid: 18842752
references.citation: Neuron. 2001 Dec 6;32(5):911-26
references.pmid: 11738035
references.citation: J Biol Chem. 2004 Nov 5;279(45):46907-14
references.pmid: 15345711
references.citation: Crit Rev Oral Biol Med. 1993;4(2):177-96
references.pmid: 8435465
references.citation: Ann Periodontol. 2002 Dec;7(1):102-11
references.pmid: 16013223
references.citation: Curr Drug Targets. 2003 Aug;4(6):461-8
references.pmid: 12866660